Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Adrenaline
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
EpiPen 300micrograms/0.3ml (1 in 1,000) inj auto-injectors
0304030C0BEABA3
|
EpiPen | Adrenaline | Respiratory System | 70,228 |
|
Jext 300micrograms/0.3ml (1 in 1,000) inj auto-injectors
0304030C0BHABA3
|
Jext | Adrenaline | Respiratory System | 16,560 |
|
EpiPen Jr. 150microg/0.3ml (1 in 2,000) inj auto-injectors
0304030C0BEAAA2
|
EpiPen | Adrenaline | Respiratory System | 16,474 |
|
Jext 150micrograms/0.15ml (1 in 1,000) inj auto-injectors
0304030C0BHAABF
|
Jext | Adrenaline | Respiratory System | 5,191 |
|
Adrenaline (base) 300mcg/0.3ml (1in1,000) inj pf dispos dev
0304030C0AAA3A3
|
Adrenaline (Anaphylactic) | Adrenaline | Respiratory System | 927 |
|
Adrenaline (base) 1mg/1ml (1 in 1,000) inj ampoules
0304030C0AAABAB
|
Adrenaline (Anaphylactic) | Adrenaline | Respiratory System | 677 |
|
Emerade 500micrograms/0.5ml (1 in 1,000) inj auto-injectors
0304030C0BIACBG
|
Emerade | Adrenaline | Respiratory System | 271 |
|
Emerade 300micrograms/0.3ml (1 in 1,000) inj auto-injectors
0304030C0BIABA3
|
Emerade | Adrenaline | Respiratory System | 179 |
|
Adrenaline (base) 1mg/1ml (1 in 1,000) inj pfs
0304030C0AAAYAY
|
Adrenaline (Anaphylactic) | Adrenaline | Respiratory System | 172 |
|
Adrenaline (base) 150mcg/0.15ml (1in1,000) inj pf dispos dev
0304030C0AABFBF
|
Adrenaline (Anaphylactic) | Adrenaline | Respiratory System | 137 |
|
Adrenaline (base) 150mcg/0.3ml (1in2,000) inj pf dispos dev
0304030C0AAA2A2
|
Adrenaline (Anaphylactic) | Adrenaline | Respiratory System | 113 |
|
Adrenaline (base) 10mg/10ml (1 in 1,000) inj ampoules
0304030C0AABDBD
|
Adrenaline (Anaphylactic) | Adrenaline | Respiratory System | 107 |
|
Emerade 150micrograms/0.15ml (1 in 1,000) inj auto-injectors
0304030C0BIAABF
|
Emerade | Adrenaline | Respiratory System | 64 |
|
Adrenaline (base) 5mg/5ml (1 in 1,000) inj ampoules
0304030C0AAAXAX
|
Adrenaline (Anaphylactic) | Adrenaline | Respiratory System | 39 |
|
Adrenaline (base) 100microg/1ml (1 in 10,000) dilute inj amp
0207030A0AAADAD
|
Adrenaline (Parenteral) | Adrenaline | Cardiovascular System | 29 |
|
Adrenaline (base) 500micrograms/0.5ml (1 in 1,000) inj amp
0304030C0AAAFAF
|
Adrenaline (Anaphylactic) | Adrenaline | Respiratory System | 25 |
|
Adrenaline (base) 1mg/10ml (1 in 10,000) dilute inj pfs
0207030A0AAABAB
|
Adrenaline (Parenteral) | Adrenaline | Cardiovascular System | 23 |
|
Adrenaline (base) 1mg/10ml (1 in 10,000) dilute inj ampoules
0207030A0AAAFAF
|
Adrenaline (Parenteral) | Adrenaline | Cardiovascular System | 9 |
|
Adrenaline (base) 500mcg/0.5ml (1in1,000) inj pf dispos dev
0304030C0AABGBG
|
Adrenaline (Anaphylactic) | Adrenaline | Respiratory System | 1 |
|
Adrenaline (base) 500microg/5ml (1 in 10,000) dilute inj amp
0207030A0AAAJAJ
|
Adrenaline (Parenteral) | Adrenaline | Cardiovascular System | 1 |
|
Adrenaline (base) 1% eye drops
1106000F0AAADAD
|
Adrenaline (Eye) | Adrenaline | Eye | No data available |
|
Adrenaline (base) 100microg/1ml (1 in 10,000) dilute inj pfs
0207030A0AAALAL
|
Adrenaline (Parenteral) | Adrenaline | Cardiovascular System | No data available |
|
Adrenaline (base) 1mg/10ml (1 in 10,000) dilute inj Minijet
0207030A0BBABAB
|
Minjet adrenaline (Sympathomimetic) | Adrenaline | Cardiovascular System | No data available |
|
Adrenaline (base) 1mg/1ml (1 in 1,000) inj Minijet 21 gauge
0304030C0BCADAY
|
Minjet adrenaline (Anaphylactic) | Adrenaline | Respiratory System | No data available |
|
Adrenaline (base) 1mg/1ml (1 in 1,000) inj Minijet 25 gauge
0304030C0BCAFAY
|
Minjet adrenaline (Anaphylactic) | Adrenaline | Respiratory System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.